E. Smith Bryan's Insider Trades & SAST Disclosures
E. Smith Bryan's most recent trade in Nasdaq Inc - Ordinary Shares - 144A was a trade of 813 Common Stock, par value $0.01 per share done at an average price of $78.3 . Disclosure was reported to the exchange on April 3, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern E. Smith Bryan.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Nasdaq Inc - Ordinary Shar... | Bryan E. Smith | EVP, CPO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 78.30 per share. | 03 Apr 2025 | 813 | 62,637 (0%) | 0% | 78.3 | 63,658 | Common Stock, par value $0.01 per share |
| Nasdaq Inc - Ordinary Shar... | Bryan E. Smith | EVP, CPO | Sale of securities on an exchange or to another person at price $ 71.81 per share. | 03 Apr 2025 | 657 | 61,980 (0%) | 0% | 71.8 | 47,179 | Common Stock, par value $0.01 per share |
| Nasdaq Inc - Ordinary Shar... | Bryan E. Smith | EVP, CPO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 7,233 | 65,985 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Nasdaq Inc - Ordinary Shar... | Bryan E. Smith | EVP, CPO | Sale of securities on an exchange or to another person at price $ 75.71 per share. | 01 Apr 2025 | 2,000 | 58,752 (0%) | 0% | 75.7 | 151,420 | Common Stock, par value $0.01 per share |
| Nasdaq Inc - Ordinary Shar... | Bryan E. Smith | EVP, CPO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.86 per share. | 01 Apr 2025 | 1,403 | 64,582 (0%) | 0% | 75.9 | 106,432 | Common Stock, par value $0.01 per share |
| Nasdaq Inc - Ordinary Shar... | Bryan E. Smith | EVP, CPO | Sale of securities on an exchange or to another person at price $ 75.67 per share. | 01 Apr 2025 | 1,132 | 63,450 (0%) | 0% | 75.7 | 85,658 | Common Stock, par value $0.01 per share |
| Nasdaq Inc - Ordinary Shar... | Bryan E. Smith | Executive Vice President | Sale of securities on an exchange or to another person at price $ 82.78 per share. | 03 Mar 2025 | 3,500 | 60,752 (0%) | 0% | 82.8 | 289,730 | Common Stock, par value $0.01 per share |
| Nasdaq Inc - Ordinary Shar... | Bryan E. Smith | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 15,410 | 70,986 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Nasdaq Inc - Ordinary Shar... | Bryan E. Smith | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 81.24 per share. | 19 Feb 2025 | 6,734 | 64,252 (0%) | 0% | 81.2 | 547,070 | Common Stock, par value $0.01 per share |
| Nasdaq Inc - Ordinary Shar... | Bryan E. Smith | Executive Vice President | Sale of securities on an exchange or to another person at price $ 81.56 per share. | 03 Feb 2025 | 3,500 | 55,576 (0%) | 0% | 81.6 | 285,460 | Common Stock, par value $0.01 per share |
| Eledon Pharmaceuticals Inc | Bryan E. Smith | General Counsel, Corporate Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2025 | 150,500 | 150,500 | - | - | Stock Option (right to buy) | |
| Eledon Pharmaceuticals Inc | Bryan E. Smith | General Counsel, Corporate Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2025 | 64,500 | 64,500 | - | - | Restricted Stock Units | |
| Eledon Pharmaceuticals Inc | Bryan E. Smith | General Counsel, Corporate Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2024 | 474,350 | 474,350 | - | - | Stock Option (right to buy) | |
| Eledon Pharmaceuticals Inc | Bryan E. Smith | General Counsel, Corporate Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 241,650 | 241,650 | - | - | Stock Option (right to buy) | |
| Nasdaq Inc - Ordinary Shar... | Bryan E. Smith | Executive Vice President | Sale of securities on an exchange or to another person at price $ 59.89 per share. | 01 May 2024 | 3,036 | 58,636 (0%) | 0% | 59.9 | 181,826 | Common Stock, par value $0.01 per share |
| Nasdaq Inc - Ordinary Shar... | Bryan E. Smith | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 8,026 | 71,554 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Nasdaq Inc - Ordinary Shar... | Bryan E. Smith | Executive Vice President | Sale of securities on an exchange or to another person at price $ 62.91 per share. | 01 Apr 2024 | 7,400 | 61,672 (0%) | 0% | 62.9 | 465,534 | Common Stock, par value $0.01 per share |
| Nasdaq Inc - Ordinary Shar... | Bryan E. Smith | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 62.29 per share. | 01 Apr 2024 | 2,482 | 69,072 (0%) | 0% | 62.3 | 154,604 | Common Stock, par value $0.01 per share |
| Nasdaq Inc - Ordinary Shar... | Bryan E. Smith | Executive Vice President | Sale of securities on an exchange or to another person at price $ 56.29 per share. | 01 Mar 2024 | 2,064 | 63,528 (0%) | 0% | 56.3 | 116,183 | Common Stock, par value $0.01 per share |
| Nasdaq Inc - Ordinary Shar... | Smith Bryan E. | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2024 | 26,631 | 77,314 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Nasdaq Inc - Ordinary Shar... | E. Smith Bryan | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 55.54 per share. | 20 Feb 2024 | 12,126 | 65,592 (0%) | 0% | 55.5 | 673,478 | Common Stock, par value $0.01 per share |
| Eledon Pharmaceuticals Inc | Bryan E. Smith | General Counsel, Corporate Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2023 | 179,000 | 179,000 | - | - | Stock Option (right to buy) | |
| Nasdaq Inc - Ordinary Shar... | Bryan E. Smith | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2023 | 4,411 | 52,494 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Nasdaq Inc - Ordinary Shar... | Bryan E. Smith | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 54.40 per share. | 03 Apr 2023 | 1,811 | 50,683 (0%) | 0% | 54.4 | 98,518 | Common Stock, par value $0.01 per share |
| Nasdaq Inc - Ordinary Shar... | Bryan E. Smith | Executive Vice President | Sale of securities on an exchange or to another person at price $ 52.51 per share. | 14 Mar 2023 | 5,000 | 48,083 (0%) | 0% | 52.5 | 262,550 | Common Stock, par value $0.01 per share |
| Nasdaq Inc - Ordinary Shar... | Bryan E. Smith | Executive Vice President | Sale of securities on an exchange or to another person at price $ 56.17 per share. | 28 Feb 2023 | 3,000 | 53,083 (0%) | 0% | 56.2 | 168,510 | Common Stock, par value $0.01 per share |
| Nasdaq Inc - Ordinary Shar... | Bryan E. Smith | Executive Vice President | Sale of securities on an exchange or to another person at price $ 57.06 per share. | 23 Feb 2023 | 6,000 | 56,083 (0%) | 0% | 57.1 | 342,360 | Common Stock, par value $0.01 per share |
| Nasdaq Inc - Ordinary Shar... | Bryan E. Smith | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2023 | 46,818 | 87,501 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Nasdaq Inc - Ordinary Shar... | Bryan E. Smith | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 57.10 per share. | 22 Feb 2023 | 25,418 | 62,083 (0%) | 0% | 57.1 | 1,451,368 | Common Stock, par value $0.01 per share |
| Eledon Pharmaceuticals Inc | Bryan E. Smith | General Counsel, Corporate Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 155,000 | 155,000 | - | - | Stock Option (right to buy) | |
| Nasdaq Inc - Ordinary Shar... | Bryan Everard Smith | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 61.76 per share. | 31 Dec 2022 | 2,292 | 40,683 (0%) | 0% | 61.8 | 141,554 | Common Stock, par value $0.01 per share |
| Nasdaq Inc - Ordinary Shar... | Bryan Everard Smith | Executive Vice President | Sale of securities on an exchange or to another person at price $ 171.76 per share. | 25 Jul 2022 | 1,079 | 14,201 (0%) | 0% | 171.8 | 185,329 | Common Stock, par value $0.01 per share |
| Nasdaq Inc - Ordinary Shar... | Bryan Everard Smith | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2022 | 1,209 | 15,640 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Nasdaq Inc - Ordinary Shar... | Bryan Everard Smith | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 181.92 per share. | 01 Apr 2022 | 360 | 15,280 (0%) | 0% | 181.9 | 65,491 | Common Stock, par value $0.01 per share |
| Eledon Pharmaceuticals Inc | Bryan E. Smith | General Counsel, Corporate Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 120,000 | 120,000 | - | - | Stock Option (right to buy) | |
| Eledon Pharmaceuticals Inc | Bryan E. Smith | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2021 | 158,500 | 158,500 | - | - | Stock Option (Right to Buy) | |
| Nasdaq Inc - Ordinary Shar... | Bryan Everard Smith | Executive Vice President | Sale of securities on an exchange or to another person at price $ 162.74 per share. | 23 Apr 2021 | 2,149 | 11,941 (0%) | 0% | 162.7 | 349,728 | Common Stock, par value $0.01 per share |
| Nasdaq Inc - Ordinary Shar... | Bryan Everard Smith | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2021 | 1,325 | 14,090 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Nasdaq Inc - Ordinary Shar... | Bryan Everard Smith | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2021 | 4,696 | 14,586 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Nasdaq Inc - Ordinary Shar... | Bryan Everard Smith | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 140.34 per share. | 23 Feb 2021 | 1,821 | 12,765 (0%) | 0% | 140.3 | 255,559 | Common Stock, par value $0.01 per share |
| Nasdaq Inc - Ordinary Shar... | Bryan Everard Smith | Executive Vice President | Sale of securities on an exchange or to another person at price $ 143.48 per share. | 04 Feb 2021 | 1,000 | 9,890 (0%) | 0% | 143.5 | 143,480 | Common Stock, par value $0.01 per share |
| Nasdaq Inc - Ordinary Shar... | Bryan Everard Smith | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 132.74 per share. | 31 Dec 2020 | 2,056 | 10,890 (0%) | 0% | 132.7 | 272,913 | Common Stock, par value $0.01 per share |
| Nasdaq Inc - Ordinary Shar... | Bryan Everard Smith | Executive Vice President | Sale of securities on an exchange or to another person at price $ 130.00 per share. | 01 Dec 2020 | 1,000 | 12,946 (0%) | 0% | 130 | 130,000 | Common Stock, par value $0.01 per share |
| Nasdaq Inc - Ordinary Shar... | Bryan Everard Smith | Executive Vice President | Sale of securities on an exchange or to another person at price $ 132.00 per share. | 11 Aug 2020 | 1,000 | 13,946 (0%) | 0% | 132 | 132,000 | Common Stock, par value $0.01 per share |
| Nasdaq Inc - Ordinary Shar... | Bryan Everard Smith | Executive Vice President | Sale of securities on an exchange or to another person at price $ 121.49 per share. | 06 Jul 2020 | 1,000 | 14,946 (0%) | 0% | 121.5 | 121,490 | Common Stock, par value $0.01 per share |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges